Morgan Stanley Expects Medtronic, Inc. (MDT) To Miss Consenus Revenue
Tweet Send to a Friend
Morgan Stanley analyst David Lewis reiterated an Overweight rating and $140.00 price target on Medtronic, Inc. (NYSE: MDT) but noted ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
